370
Views
15
CrossRef citations to date
0
Altmetric
INNER EAR

Contrast enhancement of the inner ear after intravenous administration of a standard or double dose of gadolinium contrast agents

, , , , &
Pages 1025-1031 | Received 13 Apr 2011, Accepted 14 Jun 2011, Published online: 06 Jul 2011

References

  • Teranishi M, Naganawa S, Katayama M, Sugiura M, Nakashima T. Image evaluation of endolympahtic space in fluctuating hearing loss without vertigo. Eur Arch Otorhinolaryngol 2009;266:1871–7.
  • Tagaya M, Teranishi M, Naganawa S, Iwata T, Yoshida T, Nakashima T. 3-Tesla magnetic resonance imaging obtained four hours after intravenous gadolinium injection in patients with sudden deafness. Acta Otolaryngol 2010;130:665–9.
  • Nakashima T, Naganawa S, Teranishi M, Tagaya M, Nakata S, Sone M, Endolymphatic hydrops revealed by intravenous gadolinium injection in patients with Meniere's disease. Acta Otolaryngol 2010;130:338–43.
  • Nakashima T, Naganawa S, Sugiura M, Teranishi M, Sone M, Hayashi H. Visualization of endolymphatic hydrops in patients with Ménière's disease. Laryngoscope 2007;117:415–20.
  • Naganawa S, Sugiura M, Kawamura M, Hukatsu H, Sone M, Nakashima T. Imaging of endolymphatic and perilymphatic fluid at 3T after intratympanic administration of gadolinium-diethylenetriamine pentaacetic acid. AJNR 2008;29:724–6.
  • Naganawa S, Nakashima T. Cutting edge of inner ear MRI. Acta Otolaryngol Suppl 2009;560:5–8.
  • Suzuki H, Teranishi M, Naganawa S, Nakata S, Sone M, Nakashima T. Contrast-enhanced MRI of the inner ear after intratympanic injection of meglumine gadopentetate or gadodiamide hydrate. Acta Otolaryngol 2011;131:130–5.
  • Naganawa S, Yamazaki M, Kawai H, Bokura K, Sone M, Nakashima T. Visualization of endolymphatic hydrops in Ménière's disease with single-dose intravenous gadolinium-based contrast media using heavily T2-weighted 3D-FLAIR. Magn Reson Med Sci 2010;9:237–42.
  • Mikulec AA, Hartsock JJ, Salt AN. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otol Neurotol 2008;29:1020–6.
  • Sahni RS, Paparella MM, Schachern PA, Goycoolea MV, Le CT. Thickness of the human round window membrane in different forms of otitis media. Arch Otolaryngol Head Neck Surg 1987;113:630–4.
  • Yoshioka M, Naganawa S, Sone M, Nakata S, Teranishi M, Nakashima T. Individual differences in permeability of the round window: evaluating the movement of intratympanic gadolinium into the inner ear. Otol Neurotol 2009;30:645–8.
  • Mikulec AA, Plontke SK, Hartsock JJ, Salt AN. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs: implications for local drug delivery in humans. Otol Neurotol 2009;30:131–8.
  • Tagaya M, Yamazaki M, Teranishi M, Naganawa S, Yoshida T, Otake H, Endolymphatic hydrops and blood-labyrinth barrier in Ménière's disease. Acta Otolaryngol 2011;131:474–9.
  • Zou J, Li M, Zhang Y, Zheng G, Chen D, Chen S, Transport augmentation through the blood-inner ear barriers of guinea pigs treated with 3-nitropropionic acid and patients with acute hearing loss, visualized with 3.0 T MRI. Otol Neurotol 2011;32:204–12.
  • Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Meniere's disease. American Academy of Otolaryngology–Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:181–5.
  • Naganawa S, Ishihara S, Iwano S, Kawai H, Sone M, Nakashima T. Estimation of gadolinium-induced T1-shortening with measurement of simple signal intensity ratio between the cochlea and brain parenchyma on 3D-FLAIR: correlation with T1 measurement by TI scout sequence. Magn Reson Med Sci 2010;9:17–22.
  • Tweedle MF. Physicochemical properties of Gadteridol and other magnetic resonance contrast agents. Invest Radiol Suppl 1992;1:2–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.